Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct 1;35(5):603-610.
doi: 10.1097/MOP.0000000000001286. Epub 2023 Aug 18.

A new era in cystic fibrosis care: always changing and adapting

Barry L Diener  1 , Fredy Huertero  2 , Teresa Stables-Carney  1 , Maureen Hoelzer  3 , Catherine Kier  1
Affiliations
Review

A new era in cystic fibrosis care: always changing and adapting

Barry L Diener et al. Curr Opin Pediatr. .

Abstract

Purpose of review: This review focuses on sharing the current and changing cystic fibrosis (CF) care model. This includes changes in CF care as a chronic disease with availability of new revolutionary, highly effective therapies as well as incorporation of shared decision-making, coproduction of care, quality improvement, telemedicine, and remote patient monitoring.

Recent findings: Changes in the CF management, the CF patient population, and CF care team are described as well as how CF care has adapted to these changes.

Summary: CF is a chronic, multisystem disease requiring a large specialized multidisciplinary care team for effective treatment. With improvements in CF care and new treatments, people with CF are living longer and healthier lives. As new issues arise, the CF team needs to adapt. This was highlighted by the introduction of highly effective cystic fibrosis transmembrane conductance regulator modulator therapy, which targets the cellular defect in CF, the COVID-19 pandemic, which lead to the incorporation of telehealth and remote patient monitoring into the CF care model, and the partnering with people with CF and families through shared decision-making and coproduction.

PubMed Disclaimer

References

    1. CRC Press, Walters S, Mehta A. Hodson M, Bush A, Geddes D. Epidemiology of cystic fibrosis. Cystic fibrosis 3rd ed.2007. 21–45.
    1. Goetz D, Ren CL. Review of cystic fibrosis. Pediatr Ann 2019; 48:e154–e161.
    1. Pereira SV, Ribeiro JD, Ribeiro AF, et al. Novel, rare and common pathogenic variants in the CFTR gene screened by high-throughput sequencing technology and predicted by in silico tools. Sci Rep 2019; 9:6234.
    1. Davis PB. Cystic fibrosis since 1983. Am J Respir Crit Care Med 2006; 173:475–482.
    1. Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002; 35:246–259.